Site Search
Search Results
Expand Access to Biomarker Testing in NJ.
Not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Precision medicine, which uses information about a person's own genes or proteins, is commonly used to inform treatment for diseases like cancer. Biomarker testing is an important step to accessing precision medicine and targeted therapies, which can improve quality of life and ...
Expand Access to Biomarker Testing in New Jersey
Welcome! Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more New Jersey residents can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of ...
NJ Senate Commerce Committee Advances Biomarker Testing Bill
Earlier today, Senate Bill 3098 was unanimously voted out of the Senate Commerce Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate Budget & ... & Insurance Committee approved identical legislation (Assembly Bill 4163), which now awaits a hearing in the Assembly Appropriations Committee. Biomarker testing is a precision medicine tool that utilizes information from patients’ cells to determine the right treatment at the right time ...
Biomarker Testing Bill Passes Assembly Hurdle, Vote Follows Testimony from Breast Cancer Survivors
This week, New Jersey lawmakers approved legislation to improve access to biomarker testing with a unanimous vote by the Assembly Appropriations Committee. Assembly Bill 4163 now awaits a vote on the Assembly floor. The Senate ... Committee last week, which now awaits further consideration by the Senate Budget & Appropriations Committee. Advocates with the New Jersey Biomarker Testing Coalition are hopeful that the bills will receive the necessary support to secure swift passage in the new year. Biomarker ...
NJ Assembly Financial Institutions & Insurance Committee Votes to Improve Access to Biomarker Testing
Today, the Assembly Financial Institutions & Insurance Committee voted to improve New Jerseyans’ access to biomarker testing, advancing Assembly Bill 4163 out of committee. Championed by Assemblymembers Shavonda Sumter, Gary Schaer and Shama Haider, the proposal would ensure biomarker testing is covered by New Jersey-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it would ...
Legislation Introduced to Increase New Jerseyans’ Access to Biomarker Testing, the Key to Precision Medicine
Last week, legislation that seeks to improve New Jerseyans’ access to biomarker testing was introduced in the Legislature. Biomarker testing helps connect cancer patients to the right treatment at the right time, often resulting in improved outcomes and quality of life. ...
Calls to Improve Access to Biomarker Testing in NJ Bring Together Patients, Providers & Public Health Leaders across Disease Spectrum
Key public health, patient and provider groups have come out in support of improving access to biomarker testing in New Jersey, urging lawmakers to advance and pass Assembly Bill 4163 / Senate Bill 3098 this legislative session. This fall, a broad ... Institutions & Insurance (AFI) Committee to vote in favor of A4163, which they did—unanimously—several weeks ago. Now, the New Jersey Biomarker Coalition is looking to the Assembly Appropriations and Senate Commerce Committees to take up this bill and follow the lead of their AFI ...
New Report Reveals Progress Lagging in Pancreatic Cancer
... the concerning data, local pancreatic cancer survivor Nick Pifani is optimistic and views a path forward, in part through expanded access to biomarker testing. He is calling on leaders to help to improve access to biomarker testing when Assembly Bill 4163 / Senate Bill 3098 come under consideration. Biomarker testing is an essential step in accessing ...
Legislation Aimed at Improving Health Outcomes for New Jerseyans Passes in Senate and Assembly, Awaits Governor’s Action
Yesterday, both chambers in the New Jersey State Legislature passed legislation (Assembly Bill 4163 / Senate Bill 3098) to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Murphy’s desk, providing him the ... CAN) is leading the efforts on this significant policy change to ensure more patients can get the testing needed to access precision medicine. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that can lead to ...
Governor Murphy Sets Sights on Affordability Concerns in 2025, Advocates Applaud & Urge Lawmakers to Prioritize Patients across Cancer Continuum
... barriers that inhibit people from completing the screening process. Helping patients avoid ineffective treatment through increased access to biomarker testing: “Biomarker testing provides doctors with information about what treatment their patients will best respond to, helping patients more effectively and ...